Merck KGaA (MRK) - Total Assets

Latest as of June 2026: €52.69 Billion EUR ≈ $61.60 Billion USD

Based on the latest financial reports, Merck KGaA (MRK) holds total assets worth €52.69 Billion EUR (≈ $61.60 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Merck KGaA - Total Assets Trend (2002–2025)

This chart illustrates how Merck KGaA's total assets have evolved over time, based on quarterly financial data. Also see Merck KGaA (MRK) market capitalisation for the company's overall valuation and market capitalisation.

Merck KGaA - Asset Composition Analysis

Current Asset Composition (December 2025)

Merck KGaA's total assets of €52.69 Billion consist of 25.4% current assets and 74.6% non-current assets. Review how much debt does Merck KGaA carry to assess the company's total debt and financial obligations.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	5.3%
Accounts Receivable	€4.77 Billion	9.2%
Inventory	€4.56 Billion	8.8%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€7.66 Billion	14.7%
Goodwill	€17.93 Billion	34.4%

Asset Composition Trend (2002–2025)

This chart illustrates how Merck KGaA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See MRK live share price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Merck KGaA's current assets represent 25.4% of total assets in 2025, a decrease from 41.9% in 2002.
Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 4.5% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 24.0% in 2002.
Asset Diversification: The largest asset category is goodwill at 34.4% of total assets.

Merck KGaA Competitors by Total Assets

Key competitors of Merck KGaA based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Merck KGaA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.69	1.24	1.05
Quick Ratio	1.09	0.78	0.67
Cash Ratio	0.00	0.00	0.00
Working Capital	€5.64 Billion	€2.34 Billion	€522.00 Million

Merck KGaA - Advanced Valuation Insights

This section examines the relationship between Merck KGaA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.92
Latest Market Cap to Assets Ratio	0.38
Asset Growth Rate (YoY)	1.0%
Total Assets	€52.10 Billion
Market Capitalization	$19.62 Billion USD

Valuation Analysis

Below Book Valuation: The market values Merck KGaA's assets below their book value (0.38x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Merck KGaA's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Merck KGaA (2002–2025)

The table below shows the annual total assets of Merck KGaA from 2002 to 2025.

Year	Total Assets	Change
2025-12-31	€52.10 Billion ≈ $60.91 Billion	+1.03%
2024-12-31	€51.57 Billion ≈ $60.29 Billion	+6.33%
2023-12-31	€48.49 Billion ≈ $56.70 Billion	-0.06%
2022-12-31	€48.53 Billion ≈ $56.73 Billion	+6.98%
2021-12-31	€45.36 Billion ≈ $53.03 Billion	+8.53%
2020-12-31	€41.80 Billion ≈ $48.86 Billion	-4.60%
2019-12-31	€43.81 Billion ≈ $51.22 Billion	+18.77%
2018-12-31	€36.89 Billion ≈ $43.13 Billion	+3.56%
2017-12-31	€35.62 Billion ≈ $41.64 Billion	-6.88%
2016-12-31	€38.25 Billion ≈ $44.72 Billion	+0.64%
2015-12-31	€38.01 Billion ≈ $44.43 Billion	+46.12%
2014-12-31	€26.01 Billion ≈ $30.41 Billion	+24.94%
2013-12-31	€20.82 Billion ≈ $24.34 Billion	-3.81%
2012-12-31	€21.64 Billion ≈ $25.30 Billion	-2.16%
2011-12-31	€22.12 Billion ≈ $25.86 Billion	-1.20%
2010-12-31	€22.39 Billion ≈ $26.17 Billion	+33.96%
2009-12-31	€16.71 Billion ≈ $19.54 Billion	+6.83%
2008-12-31	€15.64 Billion ≈ $18.29 Billion	+4.84%
2007-12-31	€14.92 Billion ≈ $17.45 Billion	+84.17%
2006-12-31	€8.10 Billion ≈ $9.47 Billion	+11.29%
2005-12-31	€7.28 Billion ≈ $8.51 Billion	+27.24%
2004-12-31	€5.72 Billion ≈ $6.69 Billion	-18.05%
2003-12-31	€6.98 Billion ≈ $8.16 Billion	-7.04%
2002-12-31	€7.51 Billion ≈ $8.78 Billion	--

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$19.62 Billion

€16.78 Billion EUR

Market Cap Rank

#1305 Global

#291 in Germany

Share Price

€129.85

Change (1 day)

-1.22%

52-Week Range

€102.80 - €147.50

All Time High

€220.61